Quantification of receptor-ligand binding potential in sub-striatal domains using probabilistic and template regions of interest

NeuroImage

Volumn 55, Issue 1, 2011, Pages 101-112

  del Campo, Natalia ^a,b   Tait, Roger J ^b,c   Acosta Cabronero Julio, J ^a   Hong, Young T ^a   Izquierdo Garcia, David ^a,d   Smith, Rob ^a   Aigbirhio, Franklin I ^a   Sahakian, Barbara J ^a,b   Müller, Ulrich ^a,b   Robbins, Trevor W ^b,c   Fryer, Tim D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Binding potential; Fallypride; Positron emission tomography; Quantification; Region of interest; Sub striatal

Indexed keywords

ATOMOXETINE; FALLYPRIDE F 18; METHYLPHENIDATE; PLACEBO; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; BINDING AFFINITY; CLINICAL ARTICLE; CORPUS STRIATUM; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; RADIOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING; REGIONS OF INTEREST;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZAMIDES; COMPUTER SIMULATION; CORPUS STRIATUM; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MODELS, NEUROLOGICAL; MODELS, STATISTICAL; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE; TISSUE DISTRIBUTION;

EID: 78951476539     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.11.071     Document Type: Article

References (59)

1. Acosta-Cabronero J., Williams G.B., Pereira J.M., Pengas G., Nestor P.J. The impact of skull-stripping and radio-frequency bias correction on grey-matter segmentation for voxel-based morphometry. Neuroimage 2008, 39:1654-1665.
2. Ahsan R.L., Allom R., Gousias I.S., Habib H., Turkheimer F.E., Free S., Lemieux L., Myers R., Duncan J.S., Brooks D.J., Koepp M.J., Hammers A. Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. Neuroimage 2007, 38:261-270.
3. Ardekani B.A., Guckemus S., Bachman A., Hoptman M.J., Wojtaszek M., Nierenberg J. Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans. J. Neurosci. Meth. 2005, 142:67-76.
4. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
5. Bond A., Lader M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol. 1974, 1107-1115.
6. Cervenka S., Backman L., Cselenyi Z., Halldin C., Farde L. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage 2008, 40:1287-1295.
7. Chamberlain S.R., Del Campo N., Dowson J., Muller U., Clark L., Robbins T.W., Sahakian B.J. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol. Psychiatry 2007, 62:977-984.
8. Chow T.W., Takeshita S., Honjo K., Pataky C.E., St Jacques P.L., Kusano M.L., Caldwell C.B., Ramirez J., Black S., Verhoeff N.P. Comparison of manual and semi-automated delineation of regions of interest for radioligand PET imaging analysis. BMC Nucl Med 2007, 7:2.
9. Cropley V.L., Fujita M., Innis R.B., Nathan P.J. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol. Psychiatry 2006, 59:898-907.
10. Dice L.R. Measures of the amount of ecologic association between species. Ecology 1945, 26:297-302.
11. Doerge D.R., Fogle C.M., Paule M.G., McCullagh M., Bajic S. Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2000, 14:619-623.
12. Drevets W.C., Price J.C., Kupfer D.J., Kinahan P.E., Lopresti B., Holt D., Mathis C. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 1999, 21:694-709.
13. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., Price J.L., Mathis C.A. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 2001, 49:81-96.
14. Eickhoff S.B., Stephan K.E., Mohlberg H., Grefkes C., Fink G.R., Amunts K., Zilles K. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 2005, 25:1325-1335.
15. Evans A.C., Collins D.L., Peters T.M. 3D statistical neuroanatomical models from 305 MRI volumes. Proc. IEEE-Nuclear Science Symposium and Medical Imaging Conference 1993, 1813-1817.
16. Fein G., Landman B., Tran H., Barakos J., Moon K., Di Sclafani V., Shumway R. Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputs. Neuroimage 2006, 30:1187-1195.
17. Fonov V.S., Evans A.C., McKinstry R.C., Almli C.R., Collins D.L. Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. Neuroimage 2009, 47:S102.
18. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997, 6:279-287.
19. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003, 26:317-330.
20. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 2000, 20:2369-2382.
21. Hammers A., Koepp M.J., Free S.L., Brett M., Richardson M.P., Labbe C., Cunningham V.J., Brooks D.J., Duncan J. Implementation and application of a brain template for multiple volumes of interest. Hum. Brain Mapp. 2002, 15:165-174.
22. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 2003, 19:224-247.
23. Heckemann R.A., Hajnal J.V., Aljabar P., Rueckert D., Hammers A. Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage 2006, 33:115-126.
24. Hurlemann R., Matusch A., Eickhoff S.B., Palomero-Gallagher N., Meyer P.T., Boy C., Maier W., Zilles K., Amunts K., Bauer A. Analysis of neuroreceptor PET-data based on cytoarchitectonic maximum probability maps: a feasibility study. Anat Embryol Berl 2005, 210:447-453.
25. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
26. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000, 96:451-474.
27. Kang K.W., Lee D.S., Cho J.H., Lee J.S., Yeo J.S., Lee S.K., Chung J.K., Lee M.C. Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas. Neuroimage 2001, 14:1-6.
28. Kegeles L.S., Abi-Dargham A., Frankle W.G., Gil R., Cooper T.B., Slifstein M., Hwang D.R., Huang Y., Haber S.N., Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch. Gen. Psychiatry 2010, 67:231-239.
29. Kessler R.C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Howes M.J., Jin R., Secnik K., Spencer T., Ustun T.B., Walters E.E. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol. Med. 2005, 35:245-256.
30. Kessler R.M., Ansari M.S., Riccardi P., Li R., Jayathilake K., Dawant B., Meltzer H.Y. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Neuropsychopharmacology 2005, 30:2283-2289.
31. Kessler R.M., Woodward N.D., Riccardi P., Li R., Ansari M.S., Anderson S., Dawant B., Zald D., Meltzer H.Y. Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol. Psychiatry 2009, 65:1024-1031.
32. Kinahan P.E., Rogers J.G. Analytic 3D image reconstruction using all detected events. IEEE Trans. Nucl. Sci. 1989, 36:964-968.
33. Klein A., Andersson J., Ardekani B.A., Ashburner J., Avants B., Chiang M.C., Christensen G.E., Collins D.L., Gee J., Hellier P., Song J.H., Jenkinson M., Lepage C., Rueckert D., Thompson P., Vercauteren T., Woods R.P., Mann J.J., Parsey R.V. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009, 46:786-802.
34. Klein A., Ghosh S.S., Avants B., Yeo B.T., Fischl B., Ardekani B., Gee J.C., Mann J.J., Parsey R.V. Evaluation of volume-based and surface-based brain image registration methods. Neuroimage 2010, 51:214-220.
35. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
36. Lappin J.M., Reeves S.J., Mehta M.A., Egerton A., Coulson M., Grasby P.M. Dopamine release in the human striatum: motor and cognitive tasks revisited. J. Cereb. Blood Flow Metab. 2009, 29:554-564.
37. Larisch R., Meyer W., Klimke A., Kehren F., Vosberg H., Muller-Gartner H.W. Left-right asymmetry of striatal dopamine D2 receptors. Nucl. Med. Commun. 1998, 19:781-787.
38. Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang D.R., Huang Y., Cooper T., Kegeles L., Zarahn E., Abi-Dargham A., Haber S.N., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 2003, 23:285-300.
39. Martinez D., Gil R., Slifstein M., Hwang D.R., Huang Y., Perez A., Kegeles L., Talbot P., Evans S., Krystal J., Laruelle M., Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol. Psychiatry 2005, 58:779-786.
40. Martinez D., Narendran R., Foltin R.W., Slifstein M., Hwang D.R., Broft A., Huang Y., Cooper T.B., Fischman M.W., Kleber H.D., Laruelle M. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am. J. Psychiatry 2007, 164:622-629.
41. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 2001, 21:1034-1057.
42. Nelson H. National Adult Reading Test (NART): Test Manual 1982, NFER-Nelson, Windsor, UK.
43. Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand G.S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005, 30:821-832.
44. Rousset O.G., Collins D.L., Rahmim A., Wong D.F. Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum. J. Nucl. Med. 2008, 49:1097-1106.
45. Rusjan P., Mamo D., Ginovart N., Hussey D., Vitcu I., Yasuno F., Tetsuya S., Houle S., Kapur S. An automated method for the extraction of regional data from PET images. Psychiatry Res. 2006, 147:79-89.
46. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., Fischl B. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004, 22:1060-1075.
47. Shattuck D.W., Mirza M., Adisetiyo V., Hojatkashani C., Salamon G., Narr K.L., Poldrack R.A., Bilder R.M., Toga A.W. Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage 2008, 39:1064-1080.
48. Shidahara M., Tsoumpas C., Hammers A., Boussion N., Visvikis D., Suhara T., Kanno I., Turkheimer F.E. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. Neuroimage 2009, 44:340-348.
49. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
50. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
51. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
52. Tohka J., Wallius E., Hirvonen J., Hietala J., Ruotsalainen U. Automatic extraction of caudate and putamen in [11C] raclopride PET using deformable surface models and normalized cuts. IEEE Trans. Nucl. Sci. 2006, 53:220-227.
53. Vernaleken I., Weibrich C., Siessmeier T., Buchholz H.G., Rosch F., Heinz A., Cumming P., Stoeter P., Bartenstein P., Grunder G. Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age. Neuroimage 2007, 34:870-878.
54. Volkow N.D., Wang G.J., Newcorn J., Fowler J.S., Telang F., Solanto M.V., Logan J., Wong C., Ma Y., Swanson J.M., Schulz K., Pradhan K. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007, 34:1182-1190.
55. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2007, 64:932-940.
56. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., Fowler J.S., Zhu W., Logan J., Ma Y., Pradhan K., Wong C., Swanson J.M. Evaluating dopamine reward pathway in ADHD: clinical implications. Jama 2009, 302:1084-1091.
57. Wallius E., Tohka J., Hirvonen J., Hietala J., Ruotsalainen U. Evaluation of the automatic three-dimensional delineation of caudate and putamen for PET receptor occupancy studies. Nucl. Med. Commun. 2008, 29:53-65.
58. Wang Q., Seghers D., D'Agostino E., Maes F., Vandermeulen D., Suetens P., Hammers A. Construction and validation of mean shape atlas templates for atlas-based brain image segmentation. Inf Process Med Imaging 2005, 19:689-700.
59. Yasuno F., Hasnine A.H., Suhara T., Ichimiya T., Sudo Y., Inoue M., Takano A., Ou T., Ando T., Toyama H. Template-based method for multiple volumes of interest of human brain PET images. Neuroimage 2002, 16:577-586.